After the genome of HeLa cancer cell line was published earlier this month, researchers like Jonathan Eisen at The Tree of Life noticed that the Lacks family did not appear to give its consent to have the genome published. This, adds Peter Lipson at Forbes, is a "double ethical lapse."
Registering provides access to this and other free content.
Already have an account?Login Now.
A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.
UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.
Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.
In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.